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The advent of H7N9 in early 2013 is of concern for a
number of reasons, including its capability to infect
humans, the lack of clarity in the etiology of infection,
and because the human population does not have
pre-existing immunity to the H7 subtype. Earlier
sequence analyses of H7N9 hemagglutinin (HA) point
to amino acid changes that predicted human recep-
tor binding and impinge on the antigenic characteris-
tics of the HA. Here, we report that the H7N9 HA
shows limited binding to human receptors; however,
should a single amino acid mutation occur, this
would result in structural changeswithin the receptor
binding site that allow for extensive binding to human
receptors present in the upper respiratory tract.
Furthermore, a subset of the H7N9 HA sequences
demarcating coevolving amino acids appears to be
in the antigenic regions of H7, which, in turn, could
impact effectiveness of the currentWHO-recommen-
ded prepandemic H7 vaccines.INTRODUCTION
In late March of 2013, an H7N9 influenza A virus subtype was
identified that was found to infect humans, causing rapidly pro-
gressing severe lower respiratory tract infection and mortality
(Gao et al., 2013). As of early May, 131 reported cases have
been confirmed, with most cases in mainland China. Detailed
sequencing and analysis of the human isolates of H7N9 have
offered insights into their potential origin and factors that govern
the virus’s virulence and pathogenicity (Li et al., 2013). The trans-
mission and pathogenicity associated with this virus is unantici-
pated for several reasons. First, transmission of H7 viruses from
birds to mammals has been reported only rarely (Kwon et al.,
2011). Additionally, until the advent of H7N9, human infections
with N9 subtype viruses have not been previously reported.
Finally, human infections with other H7 viruses (primarily H7N2,
H7N3, and H7N7), even with high-pathogenicity viruses contain-
ing a polybasic cleavage site in HA, have primarily resulted in1486 Cell 153, 1486–1493, June 20, 2013 ª2013 Elsevier Inc.conjunctivitis or uncomplicated illness, with few exceptions
(Fouchier et al., 2004; Hirst et al., 2004).
Analysis of newly arising H7N9 strains, including A/Shanghai/
1/2013, A/Shanghai/2/2013, and A/Anhui/1/2013, indicates that
H7N9 is a reassorted virus incorporating envelope genes from at
least two H7 strains (hemagglutinin [HA] from an H7N3 strain and
neuraminidase [NA] from an avian-adapted H7N9 strain) with the
internal genes from at least two H9N2 avian-adapted influenza
strains (Li et al., 2013). Further analysis of the H7N9 gene seg-
ments has shown the occurrence of signature amino acids asso-
ciated with adaptation to human host and virulence (summarized
in Table 2 in Gao et al. [2013]). H7N9 strains exhibit hallmark
mutations that are thought to correlate with increased virulence
and potentially transmission in animal models such as mice and
ferrets, including the E627K mutation in PB2 (which is known to
play a key role in human-to-human respiratory droplet transmis-
sion [Van Hoeven et al., 2009]). Furthermore, genetic analysis
indicates the presence of mutations, in at least some strains,
within the M2 ion channel and NA that confer drug resistance
to the adamantanes and oseltamivir, respectively.
In contrast to the above analysis, several of the hallmark fea-
tures found in highly pathogenic influenza strains (e.g., H5N1),
including the N66S mutation in PB1-F2, the aforementioned
polybasic sequence in the linker between HA1 and HA2, and
the PDZ-binding motif in C terminus of NS1, are absent in the
H7N9 human isolates analyzed to date. Within this context and
given the somewhat confounding genetic and epidemiological
evidence of the relative human-adaptation of H7N9, one of the
most important outstanding questions is the ‘‘status’’ of the HA
protein for these isolates. Characterization of the HA protein is
important given its role in virulence (Pappas et al., 2008) and
virus neutralization to pre-existing antibodies through antigenic
memory (Hensley et al., 2009). Finally, the receptor-binding
properties of HA, governing a given virus’s tissue and organismic
tropism, are one of the key factors that critically govern aerosol
transmissibility, including human-to-human transmission (Van
Hoeven et al., 2009).
Previous studies have demonstrated that one of the key prop-
erties governing human adaptation of influenza A virus is a
‘‘switch’’ in the glycan receptor-binding specificities of viral HA
(Skehel and Wiley, 2000). Therefore, together with hallmark
mutations in other genes, such as PB2, describing mutations in
HA that lead to such a ‘‘switch’’ becomes important for surveil-
lance purposes. From the standpoint of human tissue tropism,
the HA from human-adapted viruses, including pandemic
strains, shows extensive binding to the apical surface of human
upper respiratory tissues (such as trachea) and also shows char-
acteristic binding to mucin-secreting nonciliated goblet cells on
the apical surface and to submucosal glands in ferret respiratory
tract (Matrosovich et al., 2004; Nicholls et al., 2007; Srinivasan
et al., 2008). Through lectin staining, it has been demonstrated
previously that these regions in human tracheal sections pre-
dominantly display diverse glycan receptors terminated by
a2/6 sialic acid linkage (human receptors) (Srinivasan et al.,
2008; Viswanathan et al., 2010). We have previously demon-
strated with H1, H2, and H3 subtypes that this binding property
of human-adapted viruses is one of the key factors that corre-
lates with their ability to efficiently transmit via respiratory drop-
lets in ferrets—a well-established animal model to measure the
potential for airborne human-to-human transmission (Jayara-
man et al., 2011; Maines et al., 2009).
In the case of H7N9, based on the presence of a leucine res-
idue in the 226 position (H3 numbering) of the HA, earlier studies
have predicted that this HA would have strong binding to human
receptors (Gao et al., 2013; Liu et al., 2013). These recent studies
note that HA-glycan receptor interaction is a critical property of
the virus and that experimental characterization of this property
for the H7N9 subtype is important.
Here, we report the molecular and structural features of the
glycan receptor-binding site (RBS) of H7N9 HA and the experi-
mental characterization of its binding to physiological glycan
receptors in the human respiratory tract. Contrary to the pre-
dicted strong binding to human receptors, H7N9 HA shows
limited binding to these receptors in the human upper respiratory
tract when compared to human receptor binding of other
human-adapted HAs. The experimentally observed limited bind-
ing to human receptors by H7N9 HA is consistent with the
analysis of its RBS structural features. The structural and
sequence analyses further point to a single Gly228/Ser amino
acid change, which modifies the network of interresidue con-
tacts in the RBS for more optimal contacts with both avian and
human receptors. Consequently, introducing this amino acid
change in H7N9 HARBS resulted in amutant HA that extensively
bound to the apical surface of human tracheal tissue sections in
a fashion similar to that of other human-adapted HAs. Our find-
ings therefore provide important insights into the physiological
glycan receptor tropism of the current H7N9 HA. We also report
an increase in human receptor binding should a single Gly228/
Ser amino acid change occur in this HA in the context of moni-
toring the evolution of this emerging subtype, especially as it
continues to circulate in humans. Finally, we report amino acid
substitutions in the H7N9 HA sequences that distinguish the
evolution (including antigenic sites) of this recently emerged sub-
type from past H7 isolates, which, in turn, has implications for
vaccine development strategies.
RESULTS
Given that H7N9 is a newly emerged subtype, there is a limited
set of HA sequences available for this subtype to do a compre-hensive analysis of sequence evolution of its RBS. Therefore, in
order to understand glycan receptor-binding properties of H7N9
HA, we chose a representative human isolate A/Anhui/1/2013
(Anh13). Because there is no crystal structure available, we con-
structed a homology-based structural model of Anh13 HA and
compared its RBS with H3 HA (its phylogenetically closest
human-adapted HA [Figure S1 available online]). Anh13 was
chosen because it shares substantial sequence identity with
many other reported strains of H7N9, including A/Shanghai/2/
2013 and A/Hangzhou/1/2013. Additionally, as noted previously
(Gao et al., 2013), although there are changes in the HA
sequence of Anh13 compared to the HA sequence of other
reported H7N9 strains, including A/Shanghai/2/2013, the HA of
Anh13 contains a key Q226L mutation that has been reported
to be important for altered receptor specificity for group 2
viruses, including H3 and H7. As such, Anh13 (and related
viruses) are more likely than viruses such as A/Shanghai/2/
2013 to be of concern from the standpoint of altered receptor
specificity and, hence, human transmissibility.
Earlier, we defined a framework that incorporated descriptors
of the structural topology of the human glycan receptor aswell as
interamino acid interaction networks within the RBS to define
the molecular features of the RBS of H5 HA for high-avidity/
specificity binding to human glycan receptors (Chandrasekaran
et al., 2008; Soundararajan et al., 2011). We therefore compared
the molecular features of the Anh13 RBS with those of H3 HA
(from A/Aichi/1/68 or Aich68, a strain from the 1967–1968
pandemic), which was recently cocrystallized with both avian
and human receptors (Lin et al., 2012). Also of importance,
because Aich68 represents a human-adapted virus, comparison
of its HA to that of Anh13 provides an important benchmark to
address the question of whether the HA from Anh13 shares
structural characteristics with HAs of human-adapted viruses
and, if not, which structural characteristics are missing.
Structural analyses of both H7 and H3 HAs indicate that
the structural topology of the human glycan receptor bound in
the RBS of HA is such that it has a clearly defined base region
consisting of the terminal Neu5Aca2/6Galb1/ motif and
an extension region consisting of at least a disaccharide
/4GlcNAcb1/3Galb1/. On the other hand, the topology of
the avian receptor bound within the HA RBS is such that majority
of the contacts with residues within the RBS involve the terminal
Neu5Aca2/3Galb1/ motif in the base region (Figure 1). The
130 (residues 131–138), 140 (residues 140–145) and 220 (resi-
dues 219–228) loops in the RBS make critical contacts with the
disaccharide motif in the base region and thus play a key role
in dictating the avian or human receptor-binding preference
(residue position numbering is based on Aichi68 HA-glycan
cocrystal structure [Protein Data Bank ID: 2YPG]). Additionally,
residues within the 190 helix (residues 190–196) and a part of
the 150 loop (residues 156–160), if properly positioned, make
critical contacts with the extension region of the human receptor.
Taken together, these five loops and one helix in the RBS that
make contact with the base and potentially with the extension
region of the human receptor and their network of interactions
with spatially proximal residues in the RBS constitute a complete
set of molecular features that should be analyzed to understand
the receptor-binding preference of an HA. Comparison of theseCell 153, 1486–1493, June 20, 2013 ª2013 Elsevier Inc. 1487
Figure 1. Structural HA-Glycan Receptor Complexes
(A) Structural model of Anh13 H7HARBS in complex with avian receptor. The avian receptor is shown as a stick at 40% transparency with carbon atom colored in
blue. The loop and helix regions used to define molecular features of the HA RBS are shown. The side chains of the key amino acids in these regions that make
contact with the glycan receptor are shown. The side chain of Q at the 226 position observed in all other H7 HAs (prior to H7N9 outbreak) is shown as stick with
40% transparency (carbon atom colored green). The networks of interresidue interaction contacts are shown as two-dimensional maps near the corresponding
residue positions. The map is composed of circular nodes representing the amino acid positions (which are labeled above the nodes) and is colored according to
the degree of interresidue contact (lightest shade of red indicating lowest contact and darkest shade of red indicating highest contact).
(B) The structural model of Anh13 H7 HA RBS in complex with human receptor (shown as a stick with 40% transparency and carbon atom colored in
orange).
(legend continued on next page)
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Table 1. Amino Acid Differences in the RBS of Aichi68 H3 and Anh13 H7 HAs
Base (Neu5Aca2/3/6Galb1/) Extension (/4GlcNAcb1/3Galb1/4/)
HA 130 loop
140
loop 220 loop 150 loop 150 loop 190 helix
131 133 136 138 145 219 221 222 225 226 227 228 153 155 156 157 158 159 160 186 187 188 189 190 192 193 194 196
Aichi68 T N S A S S P W G L S S W T K S G S T S T N Q E T S L V
Anh13 R N T A S A P Q G L S G W L S N T D N V S T A E T K L G
The key amino acids in the 130, 140, 150, and 220 loops and 190 helix that bind to the base and extension region of the glycan receptors in Aichi68 and
Anh13 are shown. The 150 loop has amino acids (positions 153 and 155) that are involved in contacts with the sialic acid in the base region and those
that are involved in binding to extension region. See also Figure S3.features between the Anh13 and Aichi68 HA shows many simi-
larities, as well as some important differences (Table 1). First,
many of the residues in the 130 loop, 140 loop, and 220 loop
are similar between the HA of Anh13 and Aichi68. Based on
this level of similarity, we find that the network of interresidue
contacts involving these residues is also similar (Figures 1A
and 1C). The key structural differences noted in this analysis
include part of the 190 helix and the 150 loop required for contact
with the extension region of the human receptor. In the Aich68
HA, the residues interacting with the extension region include
Q189, S193, K156, and S159 (Figure 1C), whereas, in H7 HA,
these residues include K193, T158, D159, and N160 (Figure 1B).
Furthermore, in the case of the H7 HA, R131 is positioned to
make an additional contact with the extension region (Figure 1B).
In addition to the differences in the amino acids at these
positions—and also of note—are differences between Aich68
and Anh13 in the interresidue interaction network governed by
the residue at position 228. This position is a Ser in Aichi68 but
is a Gly in Anh13. The S228 position in H3 is critical for the inter-
amino acid network involving S186, T187, and E190, which
positions E190 to make critical contacts with the sialic acid of
both avian and human receptors (Figure 1C). On the other
hand, G228 in H7 HA does not possess this interamino acid
network and, therefore, the network of interresidue contacts
involving E190 in H7 is different from that of H3 HA and instead
includes 193 (and its network) and 189 (Figure 1A).
Extending this analysis, the E190 in H7 HA is positioned to
make additional contacts with the extension region instead of
the critical contact with the sialic acid in the base region
(Figure 1B). Therefore, Anh13 H7 HA lacks at least two critical
contacts involving the 190 and 226 HA positions with the
Neu5Aca2/3Galb1/ terminal motif as observed in avian-
adapted HAs. In the case of human receptor contacts, Anh13
has lower contacts with the base region owing to the absence
of the S228 residue. Our structural analysis pointed to the
H7N9 HA having a substantially lower binding to avian receptors
than typical avian-adapted Has, as well as lower binding to(C) Aichi68 H3HARBS-human receptor complex as observed in the X-ray cocrysta
residues is similar to what was shown in (A). See also Figure S1. Note the similariti
H7 HA (expanded in Table 1). On the other hand, the network involving residues in
acid differences and also by the Gly in H7 HA versus Ser in H3 HA in the 228 po
(D) The structural model of the G228/Smutant of Anh13 H7 HARBS in complex w
the mutant is more similar to that observed in H3 HA than the WT. The interresidue
in red dotted circle.
See also Figures S1 and S3.human receptors than the human-adapted H3 HAs. Further-
more, the RBS of H7N9 HA is such that a single G228/S amino
acid change would modify the interamino acid network in the
RBS to position the E190 and S228 residues for optimal contacts
with both avian and human receptors.
To validate the structural analyses, we analyzed binding of
Anh13 to tissue sections, representative of the human respira-
tory tract, which display the physiologically relevant receptors
for influenza A viruses (Figure S2A). Anh13 stained the apical
surface and submucosal region of the human trachea, which ex-
press glycans known to be receptors of human-adapted viruses
(Jayaraman et al., 2012; Shinya et al., 2006). However, the inten-
sity and the extent of tracheal apical surface staining by Anh13
were substantially lower than what is typically observed for
human-adapted HAs (Figure S2A). Furthermore, Anh13 HA
also showed minimal binding to deep-lung alveolar section—a
region that is extensively stained by avian-adapted HAs (Fig-
ure S2B). In contrast, the G228/S mutant HA showed a dra-
matic and significant increase in the extent and intensity of
staining to apical surface of the tracheal section, including exten-
sive staining of nonciliated goblet cells in a fashion similar to that
of other human-adapted HAs and Sambucus nigra agglutinin I
(SNA I) (Figures 2 and S2C). Interestingly, the G228/Smutation
also substantially increased its binding to the alveolar sections
(Figure S2B). These results are consistent with the structural
analyses of the RBS features of H7N9 HA.
Finally, in the context of H7N9 evolution, two mutations (174S
and 226L) appear to be unique to the H7N9 HA sequences. As
noted above, the residue at 226 is a critical determinant of the
receptor-binding specificity of H7 HA, with human viruses favor-
ing L/I and avian viruses favoring Q. These two positions are also
part of a larger cluster of coevolving positions (122A, 174S, 186V,
202V, and 226L), all within the 50–230 HA region, which demar-
cates the virus from its previous H7 ancestors (see the Experi-
mental Procedures). The above observations indicate that the
H7N9 HA has evolved to be distinct from its predecessors. Pre-
vious H7 strains carrying single mutations (from the coevolvingl structure (PDB ID: 2YPG). The interresidue interaction network of the key RBS
es in the network of residues in the 130, 140, and 220 loop between the H3 and
the 190 helix is quite different, and this difference is brought about by the amino
sition.
ith human receptor. Note that the network involving residues in the 190 helix in
contact networks that are different between the mutant andWT HA are shown
Cell 153, 1486–1493, June 20, 2013 ª2013 Elsevier Inc. 1489
AC D
B Figure 2. Staining of Human Trachea with
WT and G228S A/Anhui/1/13 Hemagglutinin
(A–D) Human paraffinized tissue sections were
stained with recombinant HAs expressed and
purified from 293 F cells. Specific staining by re-
combinant HA (in green) is also demarked by white
arrows. The recombinant HAs were precomplexed
with primary anti-His and Alexa fluor 488 tagged
(green) secondary antibodies (for multivalent pre-
sentation) before adding to the tissue sections. The
WT protein did not stain the trachea (A) as intensely
as the G228S mutant HA (B). The G228S HA
showed intense staining of the apical surface of the
trachea (marked by white arrow). One key feature of
the G228S protein is the staining of the submucosal
gland (C) and the goblet cells (D) in the human
trachea. The staining to goblet cells is similar to
staining by other human-adapted influenza A virus
HA (Figure S2). The tissue was counterstained with
propidium iodide (PI) shown in red. Images in (A),
(B), and (C) were captured at 253magnification and
the image in (D) was captured at 633magnification.
See also Figure S2.cluster) are predominantly from the Eurasian lineage, suggesting
that viruses from this lineage have higher potential to generate
variants when compared to the American lineage (Figure S3).
Nucleotide analyses of the RBS-proximal region of HA (residues
50–230 of HA1) of Eurasian sequences from 1902 to 2013 show
strong diversifying (positive) selection at 156 (see the Experi-
mental Procedures). The same position has been shown to be
under selection pressure in the H1 subtype as well (Li et al.,
2011).
Previously, we defined a quantitative metric to compare the
antigenicity of two HAs. Briefly, the metric, called antigenic
intactness (AI), is directly proportional to the fraction of residues
conserved in the immunodominant antigenic sites between two
HAs. In our previous work, we showed good agreement be-
tween AI values and antigenic relatedness metric computed
from ferret antisera HA inhibition (HI) cross-reactivity data (Thar-
akaraman et al., 2013), indicating that AI values could be applied
to predict vaccine-induced cross-reactive antibody responses.
Critically, strains that are antigenically related had AI > 80%,
whereas strains that are not related to each other had AI <
80% (Tharakaraman et al., 2013). Keeping 80% as the cutoff,
the AI values between the recent World Health Organization
(WHO)-recommended H7 vaccines strains (A/Canada/rv444/
2004 [H7N3], A/mallard/Netherlands/12/2000 [H7N3], and A/
New York/107/2003 [H7N2]) and the A/Anhui/1/2013 H7N9 HA
were computed. The H7N9 HA has AI values of 67%, 89%,
and 70% with A/Canada/rv444/2004 (H7N3), A/mallard/1490 Cell 153, 1486–1493, June 20, 2013 ª2013 Elsevier Inc.Netherlands/12/2000 (H7N3), and A/New
York/107/2003 (H7N2), respectively, sug-
gesting that only /mallard/Netherlands/
12/2000 (H7N3) may be effective as a vac-
cine component. However, amino acid
differences between A/Anhui/1/2013
(H7N9) and A/mallard/Netherlands/12/
2000 (H7N3) at key antigenic sites (122in site A and 188 and 189 in site B) might limit this mallard strain
to be effective.
In the context of the Q228S mutation and given that H7N9 is a
subtype that has just emerged in the human population, it is diffi-
cult to predict whether this mutation alters antibody response to
this region in this subtype. However, it is generally known that the
220 loop, which includes the 228 position, is an antigenic site for
some HA subtypes (224 and 225 are part of antigenic site Ca
in H1 subtype; 222 is part of antigenic site I-C in H2 subtype;
and 220 is part of antigenic site D in H3, a subtype that is phylo-
genetically closest to H7); thus, antibody response targeting this
region in H7N9 cannot be excluded. As such, it will be important
to complete serological analysis to confirm the vaccine implica-
tions of our AI analyses.
DISCUSSION
The emergence of an H7N9 influenza A virus subtype poses a
significant global health concern, given that it has led to severe
infection and mortality in humans. Although preliminary genetic
analysis of this subtype has led to predictions about its human
host adaptation based on hallmark genetic signatures, including
strong binding to human receptors, this virus has not yet caused
widespread infection in humans resulting from aerosol human-
to-human transmission. Earlier studies have highlighted the
importance of determining the glycan receptor-binding property
of H7N9 HA because this property is one of the many key factors
that govern human adaptation of the virus (Gao et al., 2013; Liu
et al., 2013). Therefore, in this study, we experimentally charac-
terized glycan receptor-binding properties of H7N9 HA to assess
the human adaptation of this HA. To the best of our knowledge,
this is the first report on the glycan binding data of the H7N9 HA.
Our structural analyses and binding of H7N9 HA to human res-
piratory tissues demonstrate that it possesses a distinct binding
tropism when compared to either an avian-adapted or a human-
adaptedHA. Our findings shed light on the distinct tropism of this
H7N9 HA that is contrary to the expected strong human recep-
tor-binding preference predicted from earlier sequence analyses
(Gao et al., 2013; Liu et al., 2013). This distinct tropism would
likely impinge on the aerosol transmissibility of the H7N9 viruses
in ferrets when compared to the efficient transmission observed
in the past pandemic viruses. The limited human and avian re-
ceptor binding of the H7N9 HA raises a question as to whether
this currently circulating subtype is an intermediate in the adap-
tation to the human host. Answering this question at this point
in time is limited by the availability of sequence information for
this recently emerged subtype. Nevertheless, our structural
and experimental analyses point to an important role for
G228/S amino acid change in the RBS, should it emerge in
the current H7N9 HA, in substantially increasing its binding to
human receptors in the human respiratory tract. Of note—within
the context of this study—is the increased binding of the mutant
HA to the noncilicated goblet cells in the human trachea. This is
significant because binding to goblet cells is one of the hallmarks
of human-adapted HAs (Jayaraman et al., 2012; Matrosovich
et al., 2004; Srinivasan et al., 2008). Even in cultures of differen-
tiated human airway epithelial cells, the human influenza A
viruses are found to predominantly infect noncilicated cells as
compared to avian influenza A viruses, which target the cilicated
cells (Matrosovich et al., 2004).
Previously, several groups, including us, have studied the
receptor specificity of influenza HA using ‘‘prototypic’’ glycan
arrays containing limited sets of glycans capped with a2–3 or
a2–6 linked sialic acid. We find that, in most cases with H1,
H2, and H3 HA, the observed binding on glycan array correlated
to observed binding of these HAs on physiological glycans from
respiratory tract tissue sections. However, as noted in our pre-
vious study of HA from H7N2 A/Netherlands/219/2003, we
observed that introduction of 226L and 228S resulted in signifi-
cant staining of the apical region of tracheal tissues, despite
having modest binding to a2–6 sialyalted glycans on the glycan
array (Srinivasan et al., 2013). In the present study, with Anh13,
we again observed that the presence of 226L and 228S on the
HA results in significant binding to the apical and submucosal re-
gions of the trachea that was not captured by the affinity of the
HA to limited set of glycans in the array (data not shown). This
result warrants an investigation into binding to a more diverse
set of a2–6 sialylated glycans, particularly for H7HAs, and further
highlights the need for caution in interpreting prototypic glycan
array data during surveillance of H7N9 viral evolution.
The significance of the change in residue 156 in receptor
binding or other HA function is unclear, although the neighboring
158 glycosylation is known to have an influence on human recep-
tor binding (Stevens et al., 2008). Significantly, a subset of the
H7N9-demarcating coevolving positions (122, 186, and 202)appears to be in the antigenic regions of H7, which could have
implications on the effectiveness of the current WHO-recom-
mended prepandemic H7 vaccines. Furthermore, the reported
poor immunogenicity of vaccine candidates based on H7N9 is
a key challenge for potential vaccine strategy. The fact that
the wild-type (WT) virus binds poorly to human receptor sup-
ports the notion of poor uptake by human cells to engender an
appropriate human immune response. Mutant forms of H7N9
HA, such as G228S with higher specificity to human receptors,
can potentially have important applications for the generation
of appropriate vaccine countermeasures. Of course, a critical
component of vaccine assessment is the use of serological
assays to investigate cross-reactivity of heterologous strains.
In this context, we have previously demonstrated the correlation
between AI score with cross-neutralization responses based
on WHO data (Tharakaraman et al., 2013). Taken together, the
mutations on the antigenic regions of H7N9 HA, together with
the results of the AI analysis, could impinge on H7 vaccine
development.
In summary, our study reports on the experimental glycan-
binding properties of the H7N9 HA and also reports on the
effects of a single amino acid G228/S change in dramatically
increasing glycan receptor binding of this HA. In light of the
continued circulation of H7N9 in human subtypes, our study
facilitates monitoring the evolution of H7N9, including the acqui-
sition of amino acid changes such as G228/S that would make
it closer to human adaptation. Our study warrants further inves-
tigation of introducing this single amino acid change to H7N9
virus in the context of other genetic changes characteristic of
human-adapted viruses (such as K627 in PB2) and studying its
transmission properties in ferrets. This analysis therefore sets
the stage for future in vitro studies in human respiratory tract
cell cultures and in vivo studies in ferret and mice to investigate
the replication potential, virulence, pathogenicity, and respira-
tory droplet transmission using these recombinant WT and
mutant HA H7N9 viruses. Taken together, these findings have
important implications for surveillance of H7N9mutations in clin-
ical settings, as well as for vaccine development efforts.EXPERIMENTAL PROCEDURES
Cloning, Baculovirus Synthesis, and Mammalian Expression and
Purification of HA
Anh13 WT and G228/S mutant HA sequences were codon optimized for
mammalian expression, synthesized (DNA2.0, Menlo Park, CA), and subcl-
oned into modified pcDNA3.3 vector for expression under CMV promoter. Re-
combinant expression of HA was carried out in HEK293-F FreeStyle
suspension cells (Invitrogen, Carlsbad, CA) cultured in 293-F FreeStyle
Expression Medium (Invitrogen, Carlsbad, CA) maintained at 37C, 80%
humidity, and 8% CO2. Cells were transfected with Poly-ethylene-imine Max
(PEI-MAX, PolySciences, Warrington, PA) with the HA plasmid and were har-
vested 7 days postinfection. The supernatant was collected by centrifugation,
filtered through a 0.45 mm filter system (Nalgene, Rochester, NY), and supple-
mented with 1:1,000 diluted protease inhibitor cocktail (Calbiochem filtration
and supplemented with 1:1,000 diluted protease inhibitor cocktail [EMD Milli-
pore, Billerica, MA]). HA was purified from the supernatant using His-trap
columns (GE Healthcare) on an AKTA Purifier FPLC system. Eluting fractions
containing HA were pooled, concentrated, and buffer exchanged into 13
PBS (pH 7.4) using 100 kDa MWCO spin columns (Millipore). The purified pro-
tein was quantified using the BCA method (Pierce, Rockford, IL).Cell 153, 1486–1493, June 20, 2013 ª2013 Elsevier Inc. 1491
Homology Modeling of HA
A structural model of Anh13 HA was built using the MODELER homology
modeling software. The crystal structure of A/Netherlands/219/2003 (Neth03)
HA (PDB: 4DJ6) was used as a template to build the model. The structural
model of Anh13 bound to avian receptor was constructed by superimposing
the HA1 from cocrystal structure of Neth03-avian receptor complex (PDB ID:
4DJ7) on Anh13 HA1. The structural model of Anh13 in complex with human
receptor was constructed by superimposing the HA1 from cocrystal structure
of Aichi68-human receptor complex (PDB ID: 2YPG) with HA1 of Anh13. The
final models were subject to energy minimization (500 steps conjugate
gradient + 500 steps steepest descent) with potentials assigned using AMBER
force field.
Coevolution, Phylogeny, and Selection Analyses of H7 HA
Sequences
A total of 625 nonredundant full-length H7 HA sequences were downloaded
from GISAID. To further eliminate redundancy, the sequences were grouped
according to subtype, host, year, and country, and a representative sequence
was chosen from each group. This led to a total of 231 HA sequences.
Coevolving groups of amino acids were predicted using the CAPS online
server for protein coevolution (http://bioinf.gen.tcd.ie/caps/). The results indi-
cate functionally or structurally linked regions that are subjected to strong
selective constraints. A phylogeny tree was constructed from the 231 HA
sequences using the neighbor-joining method found in MEGA 5.1 software
(http://www.megasoftware.net/). Protein-coding nucleotide sequences were
extracted for the 114 Eurasian HA sequences, and the region-encoding
residues 50–230 of HA1 were employed for finding individual codons under
diversifying/positive selection. Positively selected sites were predicted using
DataMonkey (http://www.datamonkey.org/), which uses a normalized dN-
dS > 0 at p value < 0.1 threshold to detect positive selection.
Binding of HA to Human Tissue Sections
The human tracheal epithelia has been extensively benchmarked as a tissue
section representative of the human upper respiratory tract that is a predom-
inant physiological target site for human-adapted influenza A viruses (Imai
et al., 2012; Jayaraman et al., 2012; Mansfield, 2007; Shinya et al., 2006).
The apical surface and submucosal regions of the human trachea have been
shown to predominantly display human receptors (Chandrasekaran et al.,
2008; Jayaraman et al., 2012; Shinya et al., 2006). On the other hand, human
alveolar tissue sections representative of deep lung region have been shown to
predominantly express avian receptors and are typically stained by HA from
avian-adapted influenza A viruses (Chandrasekaran et al., 2008; van Riel
et al., 2007). Paraffinized human tracheal and alveolar (US BioChain) tissue
sections were deparaffinized, rehydrated, and incubated with 1% BSA in
PBS for 30min to prevent nonspecific binding. HAwas precomplexed with pri-
mary antibody (mouse anti-63His tag, Abcam) and secondary antibody (Alexa
fluor 488 goat anti-mouse, Invitrogen) in a molar ratio of 4:2:1, respectively, for
20min on ice. The tissue bindingwas performed over two different HA concen-
trations (40 mg/ml and 20 mg/ml) by diluting the precomplexed stock HA in 1%
BSA-PBS. Tissue sections were then incubated with the HA-antibody com-
plexes for 3 hr at room temperature (RT). The tissue sections were counter-
stained by propidium iodide (Invitrogen; 1,100 in TBST). The tissue sections
were mounted and then viewed under a confocal microscope (Zeiss LSM
700 laser scanning confocal microscopy). Sialic-acid-specific binding of HAs
to tissue sections was confirmed by loss of staining after pretreatment with
Sialidase A (from Arthrobacter ureafaciens, Prozyme). This enzyme has been
demonstrated to cleave the terminal Neu5Ac from both Neu5Aca2/3Gal
and Neu5Aca2/6Gal motifs. In the case of sialidase pretreatment, tissue
sections were incubated with 0.2 units of Sialidase A for 3 hr at 37C prior to
incubation with the proteins. Pretreatment of human tissue sections with
Sialidase A resulted in complete loss of HA staining.
Capturing Network Interamino Acid Contacts for RBS Residues
The coordinates of Neth03 H7 HA-avian receptor (PDB ID: 4DJ7) and Aichi68
H3 HA-human receptor complexes (PDB ID: 2YPG) were uploaded into
the PDBePISA server (http://www.ebi.ac.uk/msd-srv/prot_int/pistart.html) to
determine key residues in the HA RBS that make contact with the correspond-1492 Cell 153, 1486–1493, June 20, 2013 ª2013 Elsevier Inc.ing glycan receptor (interface cutoff of 30% was used). For these residues,
their environment was defined using a distance threshold of 7 A˚, and the con-
tacts, including putative hydrogen bonds (including water-bridged ones),
disulfide bonds, pi bonds, polar interactions, salt bridges, and Van der Waals
interactions (nonhydrogen) occurring between pairs of residues within this
threshold distance, were computed as described previously (Soundararajan
et al., 2011). These data were assembled into an array of eight atomic interac-
tion matrices. A weighted sum of the eight atomic interaction matrices
were then computed to produce a single matrix that accounts for the strength
of atomic interaction between residue pairs within the RBS, using weights
derived from relative atomic interaction energies (Soundararajan et al.,
2011). The interresidue interaction network calculated in this fashion generates
a matrix that describes all the contacts made by critical RBS residues with
spatial proximal neighboring residues in their environment. For each element
i, j is the sum of the path scores of all paths between residues i and j. The
degree of networking score for each residue was computed by summing
across the rows of the matrix, which was meant to correspond to the extent
of ‘‘networking’’ for each residue. The degree of networking score was normal-
ized (RBSN score) with the maximum score for each protein so that the scores
varied from 0 (absence of any network) to 1 (most networked).
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Since the submission of this manuscript, a study reporting inefficient aerosol
transmissibility of H7N9 in ferrets was published. These data support our pre-
dictions and are consistent with the data presented in this study regarding the
distinct receptor tropism of H7N9 viruses. Zhu, H.,Wang, D., Kelvin, D.J., Li, L.,
Zheng, Z., Yoon, S.W., Wong, S.S., Farooqui, A., Wang, J., Banner, D., et al.
(2013). Infectivity, transmission, and pathology of humanH7N9 influenza in fer-
rets and pigs. Science. Published online May 23, 2013. http://dx.doi.org/10.
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